The B2 Dog: What Every General Practitioner Should Know About Preclinical Heart Disease With Dr. Visser
Shownotes
A newly ausculted heart murmur is a common encounter in general practice, but navigating what comes next isn’t always straightforward. In this episode of the Partner Podcast, Dr. Lance Visser, board-certified veterinary cardiologist, breaks down the essentials of myxomatous mitral valve disease, including staging and diagnostic criteria, the landmark EPIC trial data, and what the recent approval of VETMEDIN® (pimobendan) by the FDA for the preclinical B2 dogs means for clinical practice.
Sponsored by Boehringer Ingelheim
This podcast is RACE-approved for 1 hour of CE credit through August 5, 2028. Earn your CE credit here.
Contact us:
Where to find us:
- Website: CliniciansBrief.com/Podcasts
- YouTube: Youtube.com/@clinicians_brief
- Facebook: Facebook.com/CliniciansBrief
- LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
- X: @cliniciansbrief
- Instagram: @clinicians.brief
The Team:
- Beth Molleson, DVM - Host
- Sarah Pate - Producer & Project Manager, Brief Studio
- Taylor Argo- Podcast Production & Sound Editing